These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7723244)
1. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Vega GL; Toto RD; Grundy SM Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244 [TBL] [Abstract][Full Text] [Related]
2. Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome. Toto RD; Grundy SM; Vega GL Am J Nephrol; 2000; 20(1):12-7. PubMed ID: 10644862 [TBL] [Abstract][Full Text] [Related]
3. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism. Vega GL; Grundy SM Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483 [TBL] [Abstract][Full Text] [Related]
5. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia. Lindbohm N; Gylling H; Miettinen TE; Miettinen TA Clin Chim Acta; 1999 Jul; 285(1-2):69-84. PubMed ID: 10481924 [TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458 [TBL] [Abstract][Full Text] [Related]
8. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells. Krämer-Guth A; Nauck M; Pavenstädt H; Königer M; Wieland H; Schollmeyer P; Wanner C J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247 [TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M; Vega GL; Grundy SM JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321 [TBL] [Abstract][Full Text] [Related]
11. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Kissebah AH; Alfarsi S; Adams PW Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376 [TBL] [Abstract][Full Text] [Related]
12. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447 [TBL] [Abstract][Full Text] [Related]
14. Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia. Korhonen T; Savolainen MJ; Kesäniemi YA Atherosclerosis; 1999 Sep; 146(1):1-10. PubMed ID: 10487480 [TBL] [Abstract][Full Text] [Related]
15. A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients. Demant T; Mathes C; Gütlich K; Bedynek A; Steinhauer HB; Bosch T; Packard CJ; Warwick GL Kidney Int; 1998 Dec; 54(6):2064-80. PubMed ID: 9853272 [TBL] [Abstract][Full Text] [Related]
16. The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment. Dullaart RP; Gansevoort RT; Sluiter WJ; de Zeeuw D; de Jong PE Metabolism; 1996 Jun; 45(6):723-30. PubMed ID: 8637447 [TBL] [Abstract][Full Text] [Related]
18. Hypercholesterolemia with cholesterol-enriched LDL and normal levels of LDL-apolipoprotein B. Effects of the step I diet and bile acid sequestrants on the cholesterol content of LDL. Vega GL; Grundy SM Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):517-22. PubMed ID: 8624773 [TBL] [Abstract][Full Text] [Related]